ICH Guidelines, K, U. and l, H. 2025. DEVELOPMENT AND VALIDATION OF OSIMERTINIB IN TABLET DOSAGE FORM BY RP-HPLC. International Journal of Pharmacy and Analytical Research. 14, 4 (Oct. 2025), 1186–1199.